Viatris (VTRS) Revenue (2019 - 2026)
Viatris' (VTRS) quarterly Revenue came in at $3.5 billion in Q1 2026, up 7.85% year-on-year from $3.3 billion in Q1 2025, and down 6.16% quarter-over-quarter from $3.7 billion in Q4 2025.
Viatris (VTRS) Revenue (2019 - 2026) Analysis & Trends
Viatris' Revenue history runs 8 years deep, the most recent figure standing at $3.5 billion for Q1 2026.
- On a quarterly basis, Revenue rose 7.85% year-over-year to $3.5 billion in Q1 2026; TTM through Mar 2026 was $14.6 billion, a 2.14% increase from a year earlier, with the FY2025 full-year figure at $14.3 billion, down 2.67% from the prior year.
- Revenue slipped to $3.5 billion in Q1 2026 per VTRS's latest filing, from $3.7 billion in the prior quarter.
- Across five years, Revenue topped out at $4.2 billion in Q1 2022 and bottomed at $3.3 billion in Q1 2025.
- The 5-year median for Revenue is $3.8 billion (2025), against an average of $3.8 billion.
- Across the five-year window, Revenue retreated 11.18% in 2022 and grew 7.85% in 2026, its largest moves.
- Year by year, Revenue stood at $3.9 billion in 2022, then dropped by 2.89% to $3.8 billion in 2023, then dropped by 8.35% to $3.5 billion in 2024, then rose by 7.43% to $3.7 billion in 2025, then decreased by 6.16% to $3.5 billion in 2026.
- Per Business Quant, the three latest VTRS Revenue figures stand at $3.5 billion (Q1 2026), $3.7 billion (Q4 2025), and $3.8 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 106.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.51 Bn |
| Dec 31, 2025 | 3.74 Bn |
| Sep 30, 2025 | 3.76 Bn |
| Jun 30, 2025 | 3.57 Bn |
| Mar 31, 2025 | 3.25 Bn |
| Dec 31, 2024 | 3.48 Bn |
| Sep 30, 2024 | 3.75 Bn |
| Jun 30, 2024 | 3.79 Bn |
| Mar 31, 2024 | 3.66 Bn |
| Dec 31, 2023 | 3.80 Bn |
| Sep 30, 2023 | 3.93 Bn |
| Jun 30, 2023 | 3.92 Bn |
| Mar 31, 2023 | 3.73 Bn |
| Dec 31, 2022 | 3.91 Bn |
| Sep 30, 2022 | 4.07 Bn |
| Jun 30, 2022 | 4.11 Bn |
| Mar 31, 2022 | 4.18 Bn |
| Dec 31, 2021 | 4.40 Bn |
| Sep 30, 2021 | 4.52 Bn |
| Jun 30, 2021 | 4.56 Bn |